Assessing the Feasibility and Challenges of CRISPR-Cas9 for Treating Genetic Disorders
DOI:
Abstract
This study explores the potential applications of CRISPR-Cas9 technology in treating genetic disorders in Colombia, with a specific focus on thalassemia and sickle cell anemia, which disproportionately affect Afro-Colombians. Given the country’s rich genetic diversity, which includes Afro-Colombians, mestizos, and indigenous populations, the study examines how CRISPR could be tailored to address region-specific genetic mutations and improve health outcomes. The objective of this research is to assess the feasibility, challenges, and strategic implications of CRISPR for genetic disorders in Colombia, considering factors such as healthcare infrastructure, social resistance, and genetic variation. The methodology employed includes a comprehensive review of existing literature, comparative analysis of global CRISPR applications, and a synthesis of data from genetic studies specific to Colombia’s population. The findings indicate that while CRISPR offers significant promise for addressing genetic diseases, challenges such as healthcare accessibility, high costs, and the country’s genetic diversity must be overcome. Furthermore, ethical concerns regarding genetic modification must be addressed through public education and engagement. Future research should focus on expanding genetic databases, particularly for underrepresented populations, and exploring the economic and social implications of CRISPR therapies in Colombia's rural and marginalized communities. These efforts will help ensure that CRISPR technology is effectively and equitably applied to improve public health outcomes.
Downloads
Views : 1053
Downloads : 648
References
M. Wang, J. Huang, L. Chen, A. Rodriguez, and T. Anderson, “Machine Learning Algorithms in Gene Editing,” IEEE Transactions on Biomedical Engineering, vol. 71, no. 3, pp. 514-523, 2024.
P. Kumar, A. Jain, S. Lopez, and M. Chang, “The Gene Editing Juggernaut is Picking Up Speed,” IEEE Journals & Magazine, vol. 36, no. 1, pp. 24-35, 2024.
T. Lee, K. Nakamura, R. Patel, J. Park, and C. Diaz, “Exploring the Ethical Implications of CRISPR-Cas9 Genetic Modification on Viable Embryos,” in Proceedings of the IEEE Symposium on Bioinformatics and Biomedicine, pp. 112-117, 2023.
A. Smith, L. Thompson, E. Nguyen, and H. Morales, “A High-Throughput Microdroplet-Based Single Cell Transfection Method for Gene Knockout Based on the CRISPR/Cas9 System,” IEEE Transactions on Nanotechnology, vol. 23, pp. 62-71, 2024.
C. Zhang, R. Gupta, S. Wang, J. Gomez, and D. Evans, “TransCrispr: Transformer-Based Hybrid Model for Predicting CRISPR/Cas9 Single Guide RNA Cleavage Efficiency,” IEEE/ACM Transactions on Computational Biology and Bioinformatics, vol. 20, no. 2, pp. 337-348, 2023.
M. Johnson, F. Garcia, T. Singh, and P. Hernandez, “Ethical and Practical Challenges in Deploying CRISPR in Developing Nations,” in Proceedings of the International Conference on Biomedical Engineering, pp. 67-74, 2022
J. Liu, E. Ortiz, R. Brown, A. Martinez, and Y. Wang, “Advancing Gene Therapies in Diverse Populations: Case Studies and Models,” IEEE Reviews in Biomedical Engineering, vol. 16, pp. 29-42, 2023.
S. Kim, L. Baker, R. Davis, and J. Alvarez, “Genetic Diversity and Its Implications for CRISPR Therapies,” IEEE Access, vol. 10, pp. 45678-45689, 2022.
S. Hana, M. Peterson, H. McLaughlin, et al., “Highly efficient neuronal gene knockout in vivo by CRISPR-Cas9 via neonatal intracerebroventricular injection of AAV in mice,” Gene Therapy, vol. 28, pp. 646–658, 2021.
X. Lim, C. Zhang, and X. Chen, “Advances and applications of CRISPR/Cas-mediated interference in Escherichia coli,” Engineering Microbiology, vol. 4, no. 1, 2024.
Y. Hu, L. Liu, Q. Jiang, et al., “CRISPR/Cas9: A powerful tool in colorectal cancer research,” J. Exp. Clin. Cancer Res., vol. 42, 2023.
M. Pacesa, O. Pelea, and M. Jinek, “Past, present, and future of CRISPR genome editing technologies,” Cell, vol. 187, no. 5, pp. 1076–1100, 2024.
K. Tavakoli, A. Pour-Aboughadareh, F. Kianersi, P. Poczai, A. Etminan, and L. Shooshtari, “Applications of CRISPR-Cas9 as an advanced genome editing system in life sciences,” BioTech (Basel), vol. 10, no. 3, 2021.
Z. Zhao, P. Shang, P. Mohanraju, and N. Geijsen, “Prime editing: Advances and therapeutic applications,” Trends in Biotechnology, vol. 41, no. 8, pp. 1000–1012, 2023.
N. Chaachouay and L. Zidane, “Plant-derived natural products: A source for drug discovery and development,” Drugs Drug Candidates, vol. 3, no. 1, pp. 184–207, 2024.
C. Guo, X. Ma, F. Gao, and Y. Guo, “Off-target effects in CRISPR/Cas9 gene editing,” Front. Bioeng. Biotechnol., vol. 11, 2023.
M. Chehelgerdi, M. Chehelgerdi, M. Khorramian-Ghahfarokhi, et al., “Comprehensive review of CRISPR-based gene editing: Mechanisms, challenges, and applications in cancer therapy,” Mol. Cancer, vol. 23, Art. no. 9, 2024.
U. Gamage, K. Warnakulasuriya, S. Hansika, and G. N. Silva, “CRISPR gene therapy: A promising one-time therapeutic approach for transfusion-dependent β-thalassemia—CRISPR-Cas9 gene editing for β-thalassemia,” Thalass. Rep., vol. 13, no. 1, pp. 51–69, 2023.
S. H. Park and G. Bao, “CRISPR/Cas9 gene editing for curing sickle cell disease,” Transfus. Apher. Sci., vol. 60, no. 1, 2021.
T. Li, Y. Yang, H. Qi et al., “CRISPR/Cas9 therapeutics: progress and prospects,” Signal Transduction and Targeted Therapy, vol. 8, no. 36, 2023.
S. A. Abdelnour, L. Xie, A. A. Hassanin, E. Zuo, and Y. Lu, “The potential of CRISPR/Cas9 gene editing as a treatment strategy for inherited diseases,” Frontiers in Cell and Developmental Biology, vol. 9, 2021.
X. Lu, M. Zhang, G. Li, S. Zhang, J. Zhang, X. Fu, and F. Sun, “Applications and research advances in the delivery of CRISPR/Cas9 systems for the treatment of inherited diseases,” International Journal of Molecular Sciences, vol. 24, no. 17, 2023.
A. Ndudzo, A. S. Makuvise, S. Moyo, and E. D. Bobo, “CRISPR-Cas9 genome editing in crop breeding for climate change resilience: Implications for smallholder farmers in Africa,” Journal of Agriculture and Food Research, vol. 16, 2024.
A. M. Subica, “CRISPR in Public Health: The Health Equity Implications and Role of Community in Gene-Editing Research and Applications,” Am J Public Health, vol. 113, no. 8, pp. 874-882, 2023.
L. Wiley, M. Cheek, E. LaFar, et al., “The Ethics of Human Embryo Editing via CRISPR-Cas9 Technology: A Systematic Review of Ethical Arguments, Reasons, and Concerns,” HEC Forum, 2024.
